The plasma and intracellular steady-state pharmacokinetics of lopinavir/ritonavir in HIV-1-infected patients.
about
Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometryNo evidence for induction of ABC transporters in peripheral blood mononuclear cells in humans after 14 days of efavirenz treatment.Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapyDevelopment and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patientsPopulation pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patientsPlasma and intracellular pharmacokinetics of darunavir/ritonavir once daily and raltegravir once and twice daily in HIV-infected individuals.Lopinavir plasma concentrations and virological outcome with lopinavir-ritonavir monotherapy in HIV-1-infected patientsLopinavir/ritonavir in the treatment of HIV-1 infection: a review.Dosing antiretroviral medication when crossing time zones: a review.Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients.Physiologically Based Pharmacokinetic Modeling for Predicting the Effect of Intrinsic and Extrinsic Factors on Darunavir or Lopinavir Exposure Coadministered With Ritonavir.Plasma and Intracellular Antiretroviral Concentrations in HIV-Infected Patients under Short Cycles of Antiretroviral Therapy.Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir.
P2860
Q28474772-888E976A-B056-4C45-9BA7-84071102022BQ34151189-E4597088-812D-412E-9A8C-4177BA13E4CFQ34778531-FDCC0491-98FD-4248-8B20-7C9909B538D9Q35826686-DC76E5FF-A4CA-46B6-B32E-ADC6BDAE2337Q35826931-6129D592-5510-405E-A880-EF5339D401F7Q36675900-BB919A3E-3284-43AC-8FE3-3F65777213DCQ37036468-015CBAA3-6DDD-403A-A5B6-4091D736F220Q37052827-6C99040C-57F4-4B1C-8B07-E9C94731E75BQ38674015-EB0B0362-6B43-477F-B27B-3848A2D05B53Q40067527-80D6E7F0-35C3-4131-97C6-EA3214B8D666Q40189483-FF52A7AE-EA94-4A1B-A8D4-AF0EDE2DC3FFQ41644790-1639A9FA-EA08-43B6-88E3-0DE0F54430BCQ54212183-64D4B65F-AA0F-4D65-8C97-1550C61CDC10
P2860
The plasma and intracellular steady-state pharmacokinetics of lopinavir/ritonavir in HIV-1-infected patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The plasma and intracellular s ...... ir in HIV-1-infected patients.
@en
The plasma and intracellular s ...... ir in HIV-1-infected patients.
@nl
type
label
The plasma and intracellular s ...... ir in HIV-1-infected patients.
@en
The plasma and intracellular s ...... ir in HIV-1-infected patients.
@nl
prefLabel
The plasma and intracellular s ...... ir in HIV-1-infected patients.
@en
The plasma and intracellular s ...... ir in HIV-1-infected patients.
@nl
P2093
P1433
P1476
The plasma and intracellular s ...... ir in HIV-1-infected patients.
@en
P2093
Albert T A Mairuhu
Alwin D R Huitema
Eric C M van Gorp
Jan W Mulder
Jos H Beijnen
Kristel M L Crommentuyn
Pieter L Meenhorst
P304
P577
2004-10-01T00:00:00Z